Little Aston Hospital: 0121 580 7171
South Bank Hospital: 01905 362 033

Mr. Geraint Williams

Specialist interests: Cataract surgery; ocular surface inflammation and infection; corneal dystrophies and corneal transplantation; dry eye disorders; keratoconus; laser eye surgery.

Mr. Williams runs the cornea and external disease service in Worcestershire Acute Hospitals NHS Trust. He specialises in corneal and external disease including ocular surface inflammation, infection and scarring, corneal dystrophies such as Fuchs’ Endothelial Corneal Dystrophies, Keratoconus and dry eye disorders. This includes surgical management through lamellar corneal transplantation and cataract and refractive surgery in complex cornea and external diseases.

Mr. Williams trained in South Wales, the Oxford and West Midlands Deaneries. He was awarded a prestigious Wellcome Trust clinical research fellowship in 2008, completing his PhD in 2012 and achieving international prizes for his work in to scarring diseases of the ocular surface. He was an NIHR Clinical Lecturer in Ophthalmology at the University of Birmingham from 2012 to 2014. He subsequently combined his research work at the Singapore Eye Research Institute (SERI) with his clinical fellowship in the cornea and external eye disease department of the Singapore National Eye Centre (SNEC), working with international leaders in their field.

Mr. Williams is passionate about teaching and is an honorary clinical senior lecturer at the University of Birmingham. His research interests include methods to detect inflammation and progressive scarring on the ocular surface, how the immune system responds to infection and how improved measurement such as imaging systems can help detect these responses. His further interests include the role of lasers in improving outcomes in cataract and corneal surgery. He speaks widely to audiences in the UK and abroad and is a reviewer for numerous ophthalmic and scientific journals.

Research interests: Ocular Surface Immune Regulation in Health and Disease, Improved Measurement of Clinical Disease Activity and Damage.